Equities analysts predict that NutriSystem Inc. (NASDAQ:NTRI) will report $0.53 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for NutriSystem’s earnings, with the highest EPS estimate coming in at $0.55 and the lowest estimate coming in at $0.52. NutriSystem posted earnings per share of $0.49 during the same quarter last year, which would suggest a positive year-over-year growth rate of 8.2%. The company is expected to announce its next quarterly earnings report on Wednesday, October 24th.

According to Zacks, analysts expect that NutriSystem will report full-year earnings of $2.09 per share for the current year, with EPS estimates ranging from $2.06 to $2.11. For the next year, analysts anticipate that the firm will report earnings of $2.46 per share, with EPS estimates ranging from $2.41 to $2.52. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that cover NutriSystem.

NutriSystem (NASDAQ:NTRI) last announced its earnings results on Monday, July 30th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.81 by $0.06. NutriSystem had a return on equity of 43.29% and a net margin of 7.94%. The business had revenue of $191.30 million during the quarter, compared to analysts’ expectations of $189.07 million. During the same quarter in the prior year, the firm earned $0.80 earnings per share. The business’s revenue was down 1.8% compared to the same quarter last year.

NTRI has been the subject of a number of research analyst reports. Zacks Investment Research raised NutriSystem from a “hold” rating to a “buy” rating and set a $45.00 target price for the company in a report on Thursday, August 2nd. ValuEngine raised NutriSystem from a “strong sell” rating to a “sell” rating in a report on Friday, August 3rd. DA Davidson cut NutriSystem from a “buy” rating to a “neutral” rating and reduced their target price for the company from $45.00 to $40.00 in a report on Tuesday, July 31st. They noted that the move was a valuation call. Barrington Research reissued a “hold” rating on shares of NutriSystem in a report on Thursday, July 19th. Finally, B. Riley increased their target price on NutriSystem from $52.00 to $53.00 and gave the company a “buy” rating in a report on Tuesday, July 31st. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $46.50.

Shares of NutriSystem stock traded up $0.25 during mid-day trading on Friday, reaching $36.25. 21,257 shares of the stock traded hands, compared to its average volume of 494,283. NutriSystem has a fifty-two week low of $26.06 and a fifty-two week high of $60.80. The stock has a market capitalization of $1.07 billion, a P/E ratio of 18.42, a PEG ratio of 1.75 and a beta of 1.31.

The business also recently declared a quarterly dividend, which was paid on Monday, August 20th. Stockholders of record on Thursday, August 9th were given a $0.25 dividend. The ex-dividend date was Wednesday, August 8th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.76%. NutriSystem’s dividend payout ratio (DPR) is presently 51.02%.

In other news, CFO Michael P. Monahan sold 20,000 shares of the company’s stock in a transaction that occurred on Friday, July 6th. The stock was sold at an average price of $40.03, for a total value of $800,600.00. Following the completion of the sale, the chief financial officer now directly owns 72,513 shares in the company, valued at $2,902,695.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jay Herratti sold 1,930 shares of the company’s stock in a transaction that occurred on Friday, July 6th. The shares were sold at an average price of $40.00, for a total value of $77,200.00. Following the completion of the sale, the director now owns 21,504 shares of the company’s stock, valued at $860,160. The disclosure for this sale can be found here. 2.40% of the stock is owned by corporate insiders.

Several hedge funds have recently bought and sold shares of NTRI. First Mercantile Trust Co. purchased a new stake in shares of NutriSystem in the second quarter valued at approximately $119,000. US Bancorp DE grew its position in NutriSystem by 64.7% in the second quarter. US Bancorp DE now owns 3,726 shares of the company’s stock worth $143,000 after acquiring an additional 1,464 shares during the period. Itau Unibanco Holding S.A. purchased a new position in NutriSystem in the second quarter worth approximately $180,000. Independence Advisors LLC purchased a new position in NutriSystem in the second quarter worth approximately $203,000. Finally, Clinton Group Inc. purchased a new position in NutriSystem in the first quarter worth approximately $204,000.

About NutriSystem

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.

Recommended Story: NASDAQ Stock Market Explained

Get a free copy of the Zacks research report on NutriSystem (NTRI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.